| Serial Number | 97163869 |
| Word Mark | STRATEGIC CLINICAL INNOVATION ORGANIZATION (SCIO) |
| Filing Date | Thursday, December 9, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 7, 2023 |
| Registration Number | 7210095 |
| Registration Date | Tuesday, November 7, 2023 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 22, 2023 |
| Pseudo Mark | STRATEGIC CLINICAL INNOVATION ORGANIZATION STRATEGIC CLINICAL INNOVATION ORGANIZATION |
| Goods and Services | Business consulting and management in the field of medical and scientific research and development and clinical trials for biotechnology, pharmaceutical, and medical device companies, namely, assisting companies with developing business strategies and road maps for medical and scientific research and development; assisting companies in the nature of business advisory services in the field of business plan development for biotechnology, pharmaceutical, and medical device companies; assisting companies with trial feasibility in the nature of providing independent review of clinical trials for business purposes; assisting companies with clinical trials compliance, in the nature of business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical, and biotechnology companies to assist them with clinical research, clinical trials, and applications for drug approval; business concept development and implementation in the field of the pharmaceutical industry; business consulting and management in the field of clinical trials, namely, providing information management services; business management and development consulting services for clinical research organizations (CRO), drug manufacturers, and providing in-house and out-sourced business functions and activities, namely, outsourcing services and office administration services; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of biopharmaceutical companies to assist them with clinical research, clinical trials, and applications for drug approval in the fields of genetics, epigenetic, biologics and small molecule therapeutics, drugs, combination drug and device products; providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; and assisting companies with developing global regulatory approval strategies and navigating the regulatory submission and approval process, all in the nature of regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies |
| Disclaimer with Predetermined Text | "STRATEGIC CLINICAL INNOVATION ORGANIZATION" |
| Goods and Services | Providing medical and scientific research information in the field of clinical trials; consulting services for others in the field of design, planning, and implementation project management of clinical trials |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, July 18, 2023 |
| Primary Code | 035 |
| First Use Anywhere Date | Saturday, February 28, 2009 |
| First Use In Commerce Date | Saturday, February 28, 2009 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 15, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Saturday, February 28, 2009 |
| First Use In Commerce Date | Saturday, February 28, 2009 |
| Party Name | Boston Biotech Clinical Research, LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Natick, MA 01760 |
| Party Name | Boston Biotech Clinical Research, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Natick, MA 01760 |
| Party Name | Boston Biotech Clinical Research, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Natick, MA 01760 |
| Event Date | Event Description |
| Tuesday, November 7, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, November 7, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, August 22, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, August 22, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 2, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 18, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, July 18, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, July 18, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, July 18, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, July 18, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, May 3, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, May 3, 2023 | FINAL REFUSAL E-MAILED |
| Wednesday, May 3, 2023 | FINAL REFUSAL WRITTEN |
| Wednesday, March 15, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, March 14, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, March 14, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, November 16, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, November 16, 2022 | NON-FINAL ACTION E-MAILED |
| Wednesday, November 16, 2022 | NON-FINAL ACTION WRITTEN |
| Saturday, September 17, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, December 14, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, December 13, 2021 | NEW APPLICATION ENTERED |